FlexISH ® ALK/ROS1 DistinguISHTM Probe

The FlexISH ® ALK/ROS1 DistinguISHTM Probe is designed to detect rearrangements involving the ALK (anaplastic lymphoma receptor tyrosine kinase) and ROS1 (c-ros oncogene 1) gene, respectively. Using this probe, it is possible to simultaneously detect ALK and ROS1 rearrangements and, additionally, to discriminate between possible aberrations affecting these chromosomal regions.
Both, the ALK as well as the ROS1 gene, encode for transmembrane receptor tyrosine kinases. Rearrangements affecting the ALK or the ROS1 gene locus are frequently found in non-small cell lung cancer (NSCLC). ALK and ROS1 positive NSCLC patients benefit from a tyrosine kinase targeted therapy, like, e.g., crizotinib.

Probe Maps


Ordering Information

Prod. No.:Tests¹ (Volume):Registration Status²:
5 (50 µl)
20 (200 µl)

Download Information


1 Using 10 μl probe solution per test.
2 In vitro diagnostic medical device according to EU directive 98/79/EC. 
CE IVD only available in certain countries. All other countries research use only! 
Please contact your local dealer for more information.

ISO 9001
ISO 13485
ZytoVision GmbH


For ZytoVision products additional information is available, which is only valid outside the United States of America (USA). With this action you confirm that you have read this legal notice, that you agree with the terms of use, and that you are not intending to use the information provided on this website within USA.

Accept & Continue